Provention Bio, Inc. (PRVB) NASDAQ
24.98
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
24.98
+0(+0.00%)
Currency In USD
| Market Cap | 789.82M |
| Enterprise Value | 769.69M |
| P/E Ratio | -16.44 |
| PEG Ratio | -0.16 |
| Price/Sales Ratio | 184.21 |
| Price/Book Ratio | 15.32 |
| Enterprise/Revenue | 182.65 |
| Enterprise/EBITDA | -18.89 |
| Fiscal Year | December 31, 2022 |
| Most Recent Quarter | December 31, 2022 |
| Profit Margin | -8.81 |
| Operating Margin | -9.94 |
| Return On Assets | -0.48 |
| Return On Equity | 1.33 |
| Revenue | 12.9M |
| Revenue/Share | 0.17 |
| Gross Profit | 12.38M |
| EBITDA | -124.69M |
| Net Income | -113.57M |
| Diluted EPS | -1.52 |
| Total Cash | 165M |
| Total Cash/Share | 2.21 |
| Total Debt | 23.91M |
| Total Debt/Equity | 0.2 |
| Current Ratio | 1.93 |
| Book Value Per Share | 1.63 |
| 52-Week Change | 540.51 |
| 52-Week High | 25 |
| 52-Week Low | 3.19 |
| Moving Average 50 Days | 19.1 |
| Moving Average 200 Days | 10.15 |
| Average Volume | 2.84M |
| Shares Outstanding | 95.09M |
| % Held by Institutions | 0.19 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |